Last reviewed · How we verify

A (Chloraprep) — Competitive Intelligence Brief

A (Chloraprep) (A (Chloraprep)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antiseptic. Area: Infection Prevention / Dermatology.

marketed Topical antiseptic Bacterial cell membrane and proteins Infection Prevention / Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

A (Chloraprep) (A (Chloraprep)) — Instituto de Investigacion Sanitaria La Fe. Chloraprep is an antimicrobial skin antiseptic that kills bacteria and other microorganisms on the skin surface through oxidative damage.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
A (Chloraprep) TARGET A (Chloraprep) Instituto de Investigacion Sanitaria La Fe marketed Topical antiseptic Bacterial cell membrane and proteins
Adapalene-BPO Gel Adapalene-BPO Gel Galderma Brasil Ltda. marketed Retinoid + peroxide combination Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)
Chlorhexidine 0.2% Mouthrinse Chlorhexidine 0.2% Mouthrinse University of Oslo marketed Antimicrobial agent / Antiseptic Bacterial cell membrane and proteins
adapalene/benzoyl peroxide adapalene/benzoyl peroxide Galderma R&D marketed Retinoid + peroxide combination Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)
Adapalene/Benzoyl Peroxide Gel 0.3-2.5% Adapalene/Benzoyl Peroxide Gel 0.3-2.5% Derm Research, PLLC marketed Retinoid + peroxide combination Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)
Intranasal Mupirocin and Topical Chlorhexidine Intranasal Mupirocin and Topical Chlorhexidine University of Maryland, Baltimore marketed Topical antibiotic combination Bacterial isoleucyl-tRNA synthetase (mupirocin); bacterial cell membrane and proteins (chlorhexidine)
Adapalene/Benzoyl Peroxide Facial Gel Adapalene/Benzoyl Peroxide Facial Gel Bausch Health Americas, Inc. marketed Retinoid and peroxide combination Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antiseptic class)

  1. Poitiers University Hospital · 2 drugs in this class
  2. Professional Disposables International, Inc. · 2 drugs in this class
  3. Central DuPage Hospital · 2 drugs in this class
  4. Solventum US LLC · 1 drug in this class
  5. University of British Columbia · 1 drug in this class
  6. University of Iowa · 1 drug in this class
  7. C. R. Bard · 1 drug in this class
  8. Zurex Pharma, Inc. · 1 drug in this class
  9. Instituto de Investigacion Sanitaria La Fe · 1 drug in this class
  10. Johnson & Johnson Consumer Inc. (J&JCI) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). A (Chloraprep) — Competitive Intelligence Brief. https://druglandscape.com/ci/a-chloraprep. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: